Navigation Links
Herceptin is the cure for early stages of breast cancer?

Barbara Clark, who won the case that allowed her to get the drug Herceptin for her breast cancer treatment showed positive signs of recovery from the cancer. // Miss Clark, 49, had been taking the drug for four months.

But also said that there is a 50 % possibility of the cancer to come back. She was diagnosed with HER2-positive breast cancer, an aggressive form of the disease. But she was denied the drug because it was not licensed for early stage breast cancer and because her primary care trust had not budgeted for it.

She threatened to take her case to the European court of Human Rights. Then her 12-year-old foster son, Ash who was chronically ill requested the Somerset Coast Primary Care Trust. Then a panel decided that she had exceptional needs and gave her the drugs. She said that Herceptin made the cancer less aggressive.

It costs about £21,800 per patient and can increase life expectancy by 52 %. In this struggle of hers she has brought various changes, which would benefit the other breast cancer sufferers.

She said her future would involve in further campaigning for breast cancer sufferers who are in need of Herceptin. The drug has a licence for advanced breast cancer and is not officially approved for early stage disease.

Patricia Hewitt, the Health Secretary, has said that drugs should not be denied on grounds of cost alone. Roche, the drug makers are finalizing the safety data and will submit an application to the European licensing authority in the next two or three weeks.

This would then allow the drug to be made available for early cancer treatment. Then it is left to the National Institute for Health and Clinical Excellence (Nice) to decide whether Herceptin has to be used in the NHS.


'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
6. Wangaratta Community fundraising for Herceptin drug
7. Herceptin for Early Stage Breast cancer
8. Treatment of Breast Cancer with Herceptin for Nine Weeks
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Norfolk PCTs To Offer Herceptin
11. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: